9
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Formation of Stable Free Radicals from Kampo Medicines TJ-9, TJ-15, TJ-23, TJ-96, TJ-114 and their Antioxidant Effect on Low Density Lipoproteins

, , , &
Pages 227-237 | Received 22 Jan 1992, Published online: 07 Jul 2009
 

Abstract

The Japanese herbal Kampo medicines TJ-9 (A), TJ-15 (B), TJ-23 (C), TJ-114 (D) and TJ-96 (E) were effective (2-5x less than α-tocopherol) in inhibiting a copper-induced peroxidation of low density lipoprotein. Kampo medicines dissolved in n-butanol formed stable free radical(s), detected by EPR spectroscopy as a single asymmetric line with g-value g = 2.005. The radical concentration increased in the order: C < D ≈ A ≈ E < B. When the Kampo medicines were oxidized in n-butanol by excess of PbO2 their radical concentration increased 7-15 fold and was in the order C < D < A ≈ E ≪ B. A relationship between the potency of the medicines to inhibit peroxidation of LDL and their ability to form stable free radicals upon oxidation was observed. The medicine which formed more radicals was more efficient in inhibiting peroxidation of LDL. In order to study whether Kampo medicines can reduce α-tocopherol radical, the a-tocopherol radical was generated by the reaction of α-tocopherol with UV irradiated di-tert-butylperoxide and by autooxidation of α-tocopherol in n-butanol (25 μ-1) in air. In both systems vitamin-C > Kampo B decreased the concentration of the α-tocopherol radical and the EPR spectrum of Kampo B stable radical(s) appeared. The effect of other Kampo medicines was not clearly seen since their EPR spectra were superimposed with the spectrum of the α-tocopherol radical. The results indicate that Kampo medicines possess electron donor properties and ability to form stable radical(s). The results may contribute to understanding beneficial effects of Kampo medicines in diseases in which free radical damage is suggested.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.